Protagenic Therapeutics, Inc.\new - PTIX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q4 2025 · Q3 2025
Value (USD)
Total reported value ($000)
$148K
QoQ value delta ($000)
-$195K (-56.85%)
Implied price effect (QoQ)
-62.8%
Shares
Total shares
116,480
QoQ shares delta
+16,068 (+16.0%)
Total shares held by funds (by quarter)
Shares (left)

Fund holders include prior positions carried forward until a new 13F confirms a change. Reported holders have reported a position in this security for that quarter; this is not the total number of 13F filers.

Market chart (PTIX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q4 2025)

Top 25 only Full list
Early Q2 2026 data: only 2 institutional holders reported so far. More will appear as funds file with the SEC.
Manager Value ($000) Shares % of 13F
DRW Securities, LLC 55 42,854 0.0%
FNY Investment Advisers, LLC 32 25,000 0.01%
CITADEL ADVISORS LLC 30 23,311 0.0%
GEODE CAPITAL MANAGEMENT, LLC 15 12,182 0.0%
RAYMOND JAMES FINANCIAL INC 13 10,001 0.0%
Tower Research Capital LLC (TRC) 3 3,045 0.0%
BANK OF AMERICA CORP /DE/ 0 17 0.0%
MORGAN STANLEY 0 2 0.0%
HARBOR INVESTMENT ADVISORY, LLC 0 1 0.0%
CWM, LLC 0 1 0.0%
OSAIC HOLDINGS, INC. 0 49 0.0%
United Financial Planning Group LLC 0 17 0.0%